Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.72 +0.10 (+0.14%)
As of: Sep 30, 2026 · 3:59 PM EDT

Ani Pharmaceuticals (ANIP) Capital Expenditures (2010 - 2026)

Updated

Ani Pharmaceuticals (ANIP) recorded Capital Expenditures of $3.05 million in Q2 2026, down 23.9% from $4.01 million a year earlier and down 49.7% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Capital Expenditures (2010 - 2026) Analysis & Trends

On a TTM basis, Ani Pharmaceuticals' Capital Expenditures came in at $16.48 million as of Jun 30, 2026, up 20.3% year-over-year; for FY2025, it came in at $13.84 million, down 14.8% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of 17.7% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $16.24 million in FY2024 (+83.1%), $8.87 million in FY2023 (-0.1%), $8.88 million in FY2022 (+247.1%) and $2.56 million in FY2021 (-58.3%).
  • Quarterly Capital Expenditures has ranged from $356,000 in Q4 2021 to $6.1 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Capital Expenditures rose in four of the last eight quarters, with growth averaging 28.3%.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 781.5% in Q4 2022, against a decline of 83.1% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.07 million (Q1 2026), $1.24 million (Q4 2025) and $6.1 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Ani Pharmaceuticals 1.73 Bn 512.62 Mn 165.89 Mn 3.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.05 Mn
Mar 31, 2026 6.07 Mn
Dec 31, 2025 1.24 Mn
Sep 30, 2025 6.10 Mn
Jun 30, 2025 4.01 Mn
Mar 31, 2025 2.47 Mn
Dec 31, 2024 2.39 Mn
Sep 30, 2024 4.81 Mn
Jun 30, 2024 4.45 Mn
Mar 31, 2024 4.58 Mn
Dec 31, 2023 2.28 Mn
Sep 30, 2023 1.74 Mn
Jun 30, 2023 2.50 Mn
Mar 31, 2023 2.35 Mn
Dec 31, 2022 3.14 Mn
Sep 30, 2022 2.47 Mn
Jun 30, 2022 1.32 Mn
Mar 31, 2022 1.95 Mn
Dec 31, 2021 356,000.00
Sep 30, 2021 571,000.00
API Access

Ani Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ANIP&period=max&api_key=YOUR_API_KEY